Obermatt

Sonova

VTX:SOON · CH0012549785
Health Care Equipment & SuppliesX-Large

360

51
EV / EBIT41
Price / Owner Earnings37
Owner Earnings Yield53
Dividend Yield49
Price/Sales25
EV / Gross Profit56
Price/Book25
Return on Capital81
Cash Return on Capital83
Return on Equity81
EBIT Margin70
Gross Profitability74
Cash Conversion50
Accruals62
Owner Earnings Margin69
Sales growth57
Profit Growth76
Long-Term EPS Growth38
Owner Earnings Growth36
Reinvestment6
Price momentum32
Debt load44
Refinancing43
Debt Payback52
Liquidity88
Analyst ratings13
Opinion Changes47
Price Target Upside18
Market mood91
Value Creation12/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Sonova clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeX-Large
TypePublic Company
ExchangeSWX
Employees3,572
Websitesonova.com
ISINCH0012549785
Last UpdateApr 2, 2026
Themes
Assistive TechnologyEar Nose & Throat (ENT)Wearables

Description

Sonova Holding AG (Sonova) is a global leader in the healthcare industry, specifically focused on the design, development, manufacturing, and distribution of hearing instruments and cochlear implants. Established in Switzerland, the company has grown…

Analysis

Quality compounder

Sonova Holding AG earns the quality_compounder label: good underlying economics priced fairly, with no obvious bargain or excess.

On valuation, the picture is fair. The owner-earnings multiple stands at 24.2×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 9% a year, against analyst forecasts of 8%. The price, in other words, assumes less than the experts do.

Growth is tepid; the safety picture is adequate. The company scores 12/20 on our value-creation score: creating some value. Analyst sentiment is cautious.

Flags to be aware of: A large part of the company's book value is the price paid for past acquisitions. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
25
2023202420252026

All-time high

44

Jan 2025

All-time low

4

Dec 2025

Average rank

19

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
25
17
24
31
Price/Earnings
23
33
37
44
Price/Book
25
14
13
29
Dividend Yield
49
66
64
76
Value (overall)
24
50
37
55

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Sonova with its peers
Demant
CPH:DEMANT
25
CountryDenmark
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Medartis Holding
SWX:MED
33
CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Smith & Nephew
LSE:SN.
86
CountryUK
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Straumann
VTX:STMN
40
CountrySwitzerland
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →
Getinge
STO:GETI B
63
CountrySweden
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
bioMerieux
PAR:BIM
72
CountryFrance
IndustryHealth Care Equipment & Supplies
SizeLarge
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →